Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSS0343 tablets in COPD (phase II, randomized, double-blind, placebo-controlled)
CTR20260103Phase 2Active
- Sponsor
- Reistone Biopharma
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0343 in chronic obstructive pulmonary disease (COPD), sponsored by Reistone Biopharma. Started Mar 2026; status: active.
02
Drugs
RSS0343
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20260103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260103.